Extended-spectrum-cephalosporin resistance in Salmonella enterica isolates of animal origin

被引：37

作者：

Gray, JT

Hungerford, LL

Fedorka-Cray, PJ

Headrick, ML

机构：

[1] USDA ARS, Antimicrobial Resistance Res Unit, Russell Res Ctr, Athens, GA 30604 USA

[2] US FDA, Antimicrobial Resistance Res Unit, Athens, GA 30604 USA

[3] US FDA, Ctr Vet Med, Rockville, MD 20857 USA

[4] US FDA, Ctr Vet Med, Athens, GA 30605 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2004年 / 48卷 / 08期

关键词：

D O I：

10.1128/AAC.48.8.3179-3181.2004

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A total of 112 out of 5,709 Salmonella enterica isolates from domestic animal species exhibited decreased susceptibilities to ceftiofur and ceftriaxone, and each possessed the bla(CMY) gene. Ten Salmonella serotypes were significantly more likely to include resistant isolates. Isolates from turkeys, horses, cats, and dogs were significantly more likely to include resistant isolates.

引用

收藏

页码：3179 / 3181

页数：3

相关论文

共 20 条

[1]

Ausubel FM., 1993, Current Protocols in Molecular Biology

[2] Salmonella enteritidis:: AmpC plasmid-mediated inducible β-lactamase (DHA-1) with an ampR gene from Morganella morganii [J].

Barnaud, G ;

Arlet, G ;

Verdet, C ;

Gaillot, O ;

Lagrange, PH ;

Philippon, A .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2352-2358

[3] Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance [J].

Bauernfeind, A ;

Stemplinger, I ;

Jungwirth, R ;

Giamarellou, H .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :221-224

[4] THERAPY OF EXPERIMENTAL MENINGITIS DUE TO SALMONELLA-ENTERITIDIS [J].

BRYAN, JP ;

SCHELD, WM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :949-954

[5] Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998 [J].

Carattoli, A ;

Tosini, F ;

Giles, WP ;

Rupp, ME ;

Hinrichs, SH ;

Angulo, FJ ;

Barrett, TJ ;

Fey, PD .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1269-1272

[6] CEPHALOSPORIN THERAPY FOR SALMONELLOSIS - QUESTIONS OF EFFICACY AND CROSS RESISTANCE WITH AMPICILLIN [J].

CHERUBIN, CE ;

ENG, RHK ;

SMITH, SM ;

GOLDSTEIN, EJC .

ARCHIVES OF INTERNAL MEDICINE, 1986, 146 (11) :2149-2152

[7] Emergence of domestically acquired ceftriaxone-resistant Salmonella infections associated with AmpC β-lactamase [J].

Dunne, EF ;

Fey, PD ;

Kludt, P ;

Reporter, R ;

Mostashari, F ;

Shillam, P ;

Wicklund, J ;

Miller, C ;

Holland, B ;

Stamey, E ;

Barrett, TJ ;

Rasheed, JK ;

Tenover, FC ;

Ribot, EM ;

Angulo, FJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (24) :3151-3156

[8] Ceftriaxone-resistant salmonella infection acquired by a child from cattle. [J].

Fey, PD ;

Safranek, TJ ;

Rupp, ME ;

Dunne, EF ;

Ribot, E ;

Iwen, PC ;

Bradford, PA ;

Angulo, FJ ;

Hinrichs, SH .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (17) :1242-1249

[9] RAPID PROCEDURE FOR DETECTION AND ISOLATION OF LARGE AND SMALL PLASMIDS [J].

KADO, CI ;

LIU, ST .

JOURNAL OF BACTERIOLOGY, 1981, 145 (03) :1365-1373

[10] BETA-LACTAMASES IN LABORATORY AND CLINICAL RESISTANCE [J].

LIVERMORE, DM .

CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :557-&